Exceeding Cancer Study Enrollment Expectations in Spite of Pandemic

When the COVID-19 pandemic hit, one small community oncology center made adjustments that led to them enrolling three times as many patients in just five months compared to the previous five months using traditional methods. Once the organization implemented the OncWeb™ software and began working with an Inteliquet™ clinical engagement specialist, the center saw a 233% increase in patient enrollment.

In a complimentary case study from Inteliquet, see how OncWeb significantly increased cancer study patient enrollment in less than four months, despite the pandemic.

Download the
Case Study Now

What’s Inside

The challenges faced by the oncology center throughout COVID-19
The restructured processes, training, and new accountability measures
The results and how a new software platform increased patient enrollment

About Inteliquet

Inteliquet, an IQVIA business, is a leading provider of oncology solutions and insights on a mission to transform the accessibility, usability, and limitless possibilities of cancer research and real-world evidence. Through its proprietary AI/ML platform, OncWeb™, and the growing Cancer Center Research Consortium, Inteliquet ingests, normalizes, and aggregates structured and unstructured, de-identified real-world oncology data to remove barriers in patient care and inform critical strides in oncology research.